#news

Iranian Blood Transfusion Organization Newsletter – August 2020
Member News

Iranian Blood Transfusion Organization Newsletter – August 2020

The Iranian Blood Transfusion Organization (IBTO) and its most recent activities are featured on TIF’S website.
COVID-19 Update: Here’s Where We Stand Now In the Race For A Vaccine
Clinical News

COVID-19 Update: Here’s Where We Stand Now In the Race For A Vaccine

As large parts of the world prepare for a second wave of coronavirus cases governments have pinned their hopes on the rapid development of a vaccine to provide a route…
TIF’s Latest Newsletter Issue Is Out!
News

TIF’s Latest Newsletter Issue Is Out!

Our August 2020 newsletter has just been published! Read about our latest updates, including country activities, international projects, educational updates for patients with thalassaemia and haemoglobin disorders, and our novel…
AstraZeneca Resumes Final Stage Trials For Its Covid-19 vaccine After Initial Halt
Clinical News

AstraZeneca Resumes Final Stage Trials For Its Covid-19 vaccine After Initial Halt

AstraZeneca Plc and the University of Oxford have resumed the British clinical trials of its Covid-19 vaccine, after the initial suspension over concerns with a participant who fell ill. University…
Thalassemics India News Update
Member News

Thalassemics India News Update

The latest news from TIF’s Member ”Thalassemics India” in one place! In this issue you will find all the information on the new Thalassaemia Screening & Counselling Center in New…
AstraZeneca Starts U.S. Final-Stage Trial of Covid-19 Vaccine
Clinical News

AstraZeneca Starts U.S. Final-Stage Trial of Covid-19 Vaccine

AstraZeneca Plc has begun final-stage, Phase III trial of its coronavirus vaccine AZD1222 in the U.S., according to the company´s latest statement. Trial centers across the US are recruiting up to 30,000 adults aged 18 years…
Malaysian Health Minister: The Country Needs More Geneticists to Detect Thalassaemia Early
Member News

Malaysian Health Minister: The Country Needs More Geneticists to Detect Thalassaemia Early

Malaysia needs more geneticists in order to identify thalassaemia patients at an early stage, stated Health Minister Datuk Seri Dr Adham Baba, after launching the 2019 Malaysia Thalassaemia Registry (MTR)…
The eThalED Course Webinar Series Return With a New Session on Iron Monitoring in Thalassaemia
News

The eThalED Course Webinar Series Return With a New Session on Iron Monitoring in Thalassaemia

TIF´s upcoming webinar on ”Iron Monitoring in Thalassaemia”, specially designed and launched for medical specialists and healthcare professionals with a particular interest in the field of haemoglobin disorders and thalassaemia,…
IMR-687 Receives FDA Fast Track & Rare Pediatric Disease Designations for the Treatment of β-Τhalassaemia
Clinical News

IMR-687 Receives FDA Fast Track & Rare Pediatric Disease Designations for the Treatment of β-Τhalassaemia

IMARA Inc., a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of haemoglobin, announced the U.S. Food and Drug…
Coronavirus Pandemic: How Close Are We to a Vaccine?
Clinical News

Coronavirus Pandemic: How Close Are We to a Vaccine?

Researchers around the world are racing to develop a vaccine against Covid-19, with more than 140 candidate vaccines now tracked by the World Health Organization (WHO). Vaccines normally require years of testing…
Back to top button